Apellis Pharmaceuticals Inc
NASDAQ:APLS
Apellis Pharmaceuticals Inc
NASDAQ:APLS
Price:
17.72
USD
2.84%
Market Closed
Market Cap:
$2.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
US |
|
S
|
Shenzhen Kiwi Instruments Co Ltd
SSE:688045
|
CN |
|
Finwise Bancorp
NASDAQ:FINW
|
US |
|
Shenzhen Transsion Holdings Co Ltd
SSE:688036
|
CN |
|
Vef AB (publ)
STO:VEFAB
|
SE |
|
S
|
Sime Darby Plantation Bhd
KLSE:SIMEPLT
|
MY |
|
Puravankara Ltd
NSE:PURVA
|
IN |
|
Denny's Corp
NASDAQ:DENN
|
US |
|
Anghami Inc
NASDAQ:ANGH
|
AE |
|
Tradegate AG Wertpapierhandelsbank
F:T2G
|
DE |
Relative Value
The Relative Value of one
APLS
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 17.72 USD,
Apellis Pharmaceuticals Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
APLS Relative Value
HIDDEN
Multiples Across Competitors
APLS Competitors Multiples
Apellis Pharmaceuticals Inc Competitors
Apellis Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
2.2B USD | 2.2 | 100.2 | 37.9 | 39 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
366.3B USD | 6 | 87.5 | 14.5 | 20.2 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.9B USD | 109.6 | -1 710.6 | 15 890.6 | -1 794.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.8B USD | 5.2 | 24.7 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.6B USD | 5.8 | 20.2 | 12.6 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.6B USD | 9.6 | 29.2 | 22 | 23 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.5 | 17.6 | 13 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68B AUD | 3.2 | 35.2 | 11.6 | 14.6 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
